Skip to content. | Skip to navigation


Personal tools
 

Dr. Andrew P. Weng, MD, PhD

 

Andrew Weng    

Dr. Andrew P. Weng, MD, PhD
Senior Scientist, Terry Fox Laboratory


Professional Experience (Research):
• Senior Scientist, Terry Fox Laboratory, BC Cancer Agency (BCCA), since Jan 2005
• Associate Professor, Pathology & Laboratory Medicine, UBC, since Jul 2011
• Clinician Scientist, Department of Pathology, BCCA, since Jun 2004
• Assistant Professor, Pathology & Laboratory Medicine, UBC, 2004-2011
• Instructor, Department of Pathology, Harvard Medical School, 2001-2006

Professional Experience (Clinical):
• Director, Hematopathology, BCCA, since Oct 2006
• Director, Clinical Flow Cytometry Lab, BCCA, since Sep 2005
• Hematopathologist, BCCA, since Jun 2004
• Hematopathologist, Dana Farber Cancer Institute, 2001-2004
• Associate Pathologist, Brigham & Women's Hospital, 2001-2004

Contact:
Tel:          604-675-8136
Fax:         604-877-0712
Email:      aweng@bccrc.ca
Address:  Terry Fox Laboratory,  BC Cancer Agency, 675 West 10th Avenue, Vancouver BC, Canada V5Z 1L3
     

Research Interest :

My research focuses on signal transduction via the Notch receptor in lymphoid cells. Notch signaling plays an important role in directing lymphoid progenitors towards T cell fate, and when dysregulated leads to transformation of immature T cells and the development of T-cell acute lymphoblastic leukemia/lymphoma (T-ALL). By modulating Notch signals both in normal lymphoid development and in established human and mouse T-ALL tumors, we have been investigating molecular events responsible for cell fate determination and oncogenic transformation. Many of our findings have direct relevance to the development of rational therapies in the treatment of T-ALL.  

More Information: 

Visit Dr. Weng's page on the Terry Fox Laboratory Website for publication list, lab members, and other details.